Skin Infection - McKnight's Long Term Care News

Skin Infection

Through thick and thin

Through thick and thin

Age, health declines may lead to skin breakdowns, but judicious use of products paired with nutritional and incontinence interventions can lessen the pain

FDA approves drug to treat MRSA skin infections

The Food and Drug Administration has approved Dalvance (dalbavancin), an antibacterial drug used to treat adults with bacterial skin and skin structure infections. Among them are infections caused by Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant strains) and Streptococcus pyogenes.

Next post in News